SCHEMBL6438664

SCHEMBL6438664

CC1=C(C)C(C)C([Si](C)(C)NCc2ccccc2)=C1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CYP3A4 P08684 3/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HTT P42858 1/20 0.34
TP53 P04637 1/20 0.34
THRB P10828 1/20 0.34
CYP1A2 P05177 3/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C19 P33261 2/20 0.34
GLA P06280 1/20 0.34
HPGD P15428 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
EGFR P00533 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
FUCA1 P04066 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8722324 0.97 MEN1 (0.37) MEN1KMT2ACYP3A4KDM4EMAPT
Hydrochloric Acid SCHEMBL8722331 0.97 MEN1 (0.37) MEN1KMT2ACYP3A4KDM4EMAPT
Hydrochloric Acid SCHEMBL17836052 0.73
SCHEMBL5975482 0.71 MAOB (0.33)
SCHEMBL5975478 0.71 MAOB (0.33)
SCHEMBL11099246 0.70 CYP3A4 (0.46) MEN1KMT2ACYP3A4KDM4EMAPT
SCHEMBL12816634 0.70 CALM1 (0.39)
SCHEMBL10318475 0.70 AOC3 (0.30)
SCHEMBL6439072 0.70 BCAT2 (0.40) MEN1KMT2ACYP3A4KDM4EMAPT
SCHEMBL10320464 0.69 ESR1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6884857-B1 Olefin polymerization process using supported constrained geometry catalysts THE DOW CHEMICAL COMPANY (US) 2005-04-26 US disclosed
US-6858557-B1 Supported constrained geometry olefin polymerization catalysts THE DOW CHEMICAL COMPANY (US) 2005-02-22 US disclosed
US-6806326-B2 TITANIUM COMPLEXES WITH DELOCALIZED PI-BONDED CYCLOPENTADIENYL MOIETY, AND COCATALYST; FOR EXAMPLE, 1-(TERT-BUTYLAMIDO)-2-(TETRAMETHYLCYCLOPENTADIENYL)-ETHANEDIYL TITANIUM DICHLORIDE AND METHYL ALUMOXANE THE DOW CHEMICAL COMPANY 2004-10-19 US disclosed
US-6686488-B2 USING COORDINATION POLYMERIZATION CATALYSTS THE DOW CHEMICAL COMPANY 2004-02-03 US disclosed
US-6670432-B1 Metal is bound to a delocalized substituted pi-bonded moiety (cyclopentadiene) to induce a constrained geometry about the metal; ethylene-styrene copolymer THE DOW CHEMICAL COMPANY 2003-12-30 US disclosed
US-20030065203-A1 Constrained geometry addition polymerization catalysts WILSON DAVID R (US) 2003-04-03 US disclosed
US-20020128403-A1 Constrained geometry addition polymerization catalysts STEVENS JAMES C (US) 2002-09-12 US disclosed
US-6075077-A ETHYLENE COPOLYMER PREPARED USING A CYCLOPENTADIENE COORDINATION COMPLEX OF GIVEN FORMULA WHERE METAL IS BOUND TO A DELOCALIZED SUBSTITUTED PI-BONDED MOIETY TO INDUCE A CONSTRAINED GEOMETRY ABOUT THE METAL, AND COCATALYST THE DOW CHEMICAL COMPANY (US) 2000-06-13 US disclosed
US-6013819-A AS POLYMERIZATION CATALYSTS FOR PRODUCING ADDITION POLYMERS THE DOW CHEMICAL COMPANY (US) 2000-01-11 US disclosed
US-5703187-A ETHYLENICALLY UNSATURATED ADDITION POLYMERS THE DOW CHEMICAL COMPANY (US) 1997-12-30 US disclosed
EP-0774468-A2 Constrained geometry addition polymerization catalysts, processes for their preparation, precursors therefor, methods of use, and novel polymers formed therewith THE DOW CHEMICAL COMPANY (US) 1997-05-21 EP disclosed
EP-0765888-A2 Polymers obtainable with a constrained geometry addition polymerization catalyst and process of making atactic alpha-olefin polymers with such catalysts THE DOW CHEMICAL COMPANY (US) 1997-04-02 EP disclosed
EP-0764654-A2 Constrained geometry addition polymerization catalysts, processes for their preparation, precursors therefor, methods of use, and novel polymers formed therewith THE DOW CHEMICAL COMPANY (US) 1997-03-26 EP disclosed
EP-0764664-A2 Constrained geometry addition polymerization catalysts, processes for their preparation, precursors therefor, methods of use, and novel polymers formed therewith THE DOW CHEMICAL COMPANY (US) 1997-03-26 EP disclosed
EP-0764653-A2 Constrained geometry addition polymerization catalysts, processes for their preparation, precursors therefor, methods of use, and novel polymers formed therewith THE DOW CHEMICAL COMPANY (US) 1997-03-26 EP disclosed
EP-0416815-A2 Constrained geometry addition polymerization catalysts, processes for their preparation, precursors therefor, methods of use, and novel polymers formed therewith THE DOW CHEMICAL COMPANY (US) 1991-03-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065203-A1 Constrained geometry addition polymerization catalysts CPSF6, CPSF1, PICALM MEN1 4260/4885KMT2A 2906/4885CYP3A4 1876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.